MONTREAL, April 25,
2023 /CNW/ - The Good Shroom Co Inc. (the
"Company") provides an update on sales of various products
and grant of options.
The Corporation announces that it has granted a total of 500,000
share purchase options to its directors and officers, pursuant to
the Corporation's 10% rolling stock option plan, each having an
exercise price of $0.16 and expiring
March 30, 2030. Half of the options
vested immediately and the remaining 250,000 will vest March 30, 2024.
Sales Activities
- In early April 2023 the Company
transitioned Sky Cuddler Kush Bio and Cherry Blossom cannabis flowers from
approximately 25% of Quebec
cannabis stores to all stores.
- Also in April 2023 the Company
launched Habibi Kush hash in
Quebec.
- OG Jerk, THC infused beef jerky, remains the #1 selling
Cannabis edible in Quebec in terms
of weekly units sold and in total revenue (according to
https://quebec.weedcrawler.ca/best_sellers).
- The Company expects to launch a variety of its products in
Alberta sometime during the
summer of 2023 including OG Jerk and a variety of infused
joints.
- Afghan Gold and "Joints Infusés d'Afghan Gold"
maintain their top 10 selling positions in their respective
categories (according to
https://quebec.weedcrawler.ca/best_sellers).
The company's CEO Mr. Eric
Ronsse stated "I encourage shareholders and prospective
investors to pay close attention to the results of our third
quarter ended April 30 2023 to be
disseminated prior to June 30
2023."
About the Company
MUSH operates a portfolio of brands which include traditional
cannabis and beverage products. It exists to promote the use of
functional ingredients such as probiotics and functional mushrooms
in consumer products.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Cautionary Note Regarding
Forward-Looking Information
This press release contains statements which constitute
"forward-looking statements" and "forward-looking information"
within the meaning of applicable securities laws, including
statements regarding the plans, intentions, beliefs and current
expectations of the Corporation with respect to future business
activities and sales, including the anticipated orders to be placed
by the SQDC. Forward-looking statements are often identified by the
words "may", "would", "could", "should", "will", "intend", "plan",
"anticipate", "believe", "estimate", "expect" or similar
expressions. Investors are cautioned that forward-looking
statements are not based on historical facts but instead reflect
the Corporation's expectations, estimates or projections concerning
future results or events based on the opinions, assumptions and
estimates of management considered reasonable at the date the
statements are made. Although the Corporation believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed thereon, as unknown or
unpredictable factors could have material adverse effects on future
results, performance or achievements. Among the key factors that
could cause actual results to differ materially from those
projected are the following: market acceptance of the
Company's hash and other cannabis products, changes in the vendor's
business or strategy, changes in our supplier's operations and
pricing, expectations regarding competition and their pricing
strategy; maintaining in good standing all necessary regulatory
licenses and authorizations for its products; the benefits, safety,
efficacy, dosing and social acceptance of cannabis related products
and no material changes in the legal environment; changes in
applicable laws and regulations compliance with extensive
government regulation; operational risks related to and COVID-19 or
other pandemic and supply chain disruptions and shortages.
Should one or more of these risks or uncertainties materialize, or
should assumptions underlying the forward-looking statements prove
incorrect, actual results may vary materially from those described
herein as intended, planned, anticipated, believed, estimated or
expected. Although the Company has attempted to identify important
risks, uncertainties and factors which could cause actual results
to differ materially, there may be others that cause results not to
be as anticipated, estimated or intended and such changes could be
material. The Company does not intend, and do not assume any
obligation, to update the forward-looking statements except as
otherwise required by applicable law. Trading in the
securities of the Company should be considered highly
speculative.
SOURCE The Good Shroom Co Inc.